Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Insight into oligodendrocytes in the brain could shed light on the causes of neurodegenerative diseases

New research may help scientists locate immature cells in the central nervous system that could shed light on the causes of neurodegenerative diseases like multiple sclerosis - and autoimmune disease that affects the brain and nervous system - and allow for the development of better therapeutic treatments.

12 Mar 2022

Ketogenic diet leads to significant improvements in MS symptoms

Patients with relapsing-remitting multiple sclerosis (MS) who adopted a high-fat, low-carbohydrate ketogenic diet saw significant improvements in their MS – including reductions in neurologic disability, fatigue and depression and heightened overall quality of life, a new study finds.

8 Mar 2022

Relationship between immunological responses in the acute phase of SARS-CoV-2 infection and long-term cognitive deficits

A recent study reported that monocytosis during the acute phase of coronavirus disease 2019 could forecast anosognosia in long COVID.

8 Mar 2022

Study may pave the way for better multiple sclerosis drugs

Investigators from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have discovered how a drug for multiple sclerosis interacts with its targets, a finding that may pave the way for better treatments.

4 Mar 2022

New type of drug delivery vehicle mimics the properties of a red blood cell

From the liver to the kidneys to the lungs, the human body is equipped with many levels of filters, which protect the body from harmful outside materials. But this system also has its downsides. Critically important drugs such as chemotherapy or multiple sclerosis treatments are also foreign materials, so the body filters out a large portion of these drugs – up to 90%, in some cases.

2 Mar 2022

Telehealth services were highly utilized by individuals with multiple sclerosis during COVID-19

While many people skipped regular health check-ups during the COVID-19 pandemic, new research indicates that people with multiple sclerosis (MS) used online telehealth services more frequently to keep in contact with their health care providers and were highly satisfied with the outcome.

1 Mar 2022

A ubiquitous protein may be key to the survival of neurons most impacted by glaucoma

A ubiquitous protein called sigma 1 receptor, which is known to protect cells from stress, appears key to the function and survival of the neurons most impacted by glaucoma, scientists report.

1 Mar 2022

Cow's milk protein can trigger inflammation in multiple sclerosis sufferers

Multiple sclerosis sufferers often complain of more severe disease symptoms after consuming dairy products. Researchers at the Universities of Bonn and Erlangen-Nuremberg have now found a possible cause for this.

1 Mar 2022

Researchers demonstrate the powerful gene silencing effects of HDO technology

T and B lymphocytes, which are part of a group of immune cells commonly called white blood cells, work together to eliminate foreign invaders in the body such as viruses.

28 Feb 2022

Study shows the impact of gender-affirming hormone therapy on epigenetic signature of genes

Gender-affirming hormone therapy could influence the way a person's genes are turned on or off, according to a new study.

28 Feb 2022

People with better physical fitness are less likely to develop Alzheimer's disease

People who are more physically fit are less likely to develop Alzheimer's disease than people who are less physically fit, according to a preliminary study released today, February 27, 2022, that will be presented at the American Academy of Neurology's 74th Annual Meeting being held in person in Seattle, April 2 to 7, 2022 and virtually, April 24 to 26, 2022.

28 Feb 2022

Discovery of signaling pathway in immune cells may lead to new therapeutic approach for autoimmune diseases

Autoimmune diseases are triggered when the immune system malfunctions and attacks the body's own structures.

23 Feb 2022

Study reveals the various ways patients with multiple sclerosis acquire disability

A new study conducted by researchers from the Corrine Goldsmith Dickinson Center for Multiple Sclerosis at Icahn School of Medicine at Mount Sinai in collaboration with Novartis, the University of Oxford and key MS experts across the globe, has revealed detailed information on the various ways patients with multiple sclerosis (MS) acquire disability.

23 Feb 2022

Covid still threatens millions of Americans. Why are we so eager to move on?

Iesha White is so fed up with the U.S. response to covid-19 that she's seriously considering moving to Europe.

22 Feb 2022

Spectrum of autoantibodies linked to autoimmune diseases in patients with different COVID-19 clinical outcomes

A broad evaluation of autoimmune disease-associated autoantibodies that have been observed in COVID-19 patients was performed.

22 Feb 2022

Researchers discover how pre-transplant chemotherapy facilitates the replacement of microglial cells

More than 50,000 bone marrow-derived stem cell transplants are performed worldwide each year to treat a wide range of conditions, including brain diseases.

21 Feb 2022

Twin study identifies the influence of environment and genetics in multiple sclerosis

Researchers at the University of Zurich and Munich's LMU Klinikum hospital have studied the immune system of pairs of monozygotic twins to identify the influence of the environment and of genetics in cases of multiple sclerosis.

16 Feb 2022

Induction and stability of vaccine-specific antibodies in multiple sclerosis patients on different disease-modifying therapies

Researchers have investigated the lack of response to treatment in certain multiple sclerosis patients.

9 Feb 2022

Using sugar molecules for in vivo tracking of unlabeled stem cells

A Johns Hopkins Medicine scientist who spent 30 years figuring out how to put chemical labels into cells to track their movement in living tissues has found that certain self-renewing stem cells have built-in tracers - made out of sugars - that can do the job without added chemical "labels" when injected into mouse brains.

8 Feb 2022

Researchers investigate how discontinuing the multiple sclerosis drug affects expectant mothers

MS relapses of clinical relevance are known to occur in up to 80 per cent of patients within four to seven months of stopping natalizumab. It is also a known fact that pregnancy has a mitigating effect on the disease.

4 Feb 2022

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Insight into oligodendrocytes in the brain could shed light on the causes of neurodegenerative diseases

Ketogenic diet leads to significant improvements in MS symptoms

Relationship between immunological responses in the acute phase of SARS-CoV-2 infection and long-term cognitive deficits

Study may pave the way for better multiple sclerosis drugs

New type of drug delivery vehicle mimics the properties of a red blood cell

Telehealth services were highly utilized by individuals with multiple sclerosis during COVID-19

A ubiquitous protein may be key to the survival of neurons most impacted by glaucoma

Cow's milk protein can trigger inflammation in multiple sclerosis sufferers

Researchers demonstrate the powerful gene silencing effects of HDO technology

Study shows the impact of gender-affirming hormone therapy on epigenetic signature of genes

People with better physical fitness are less likely to develop Alzheimer's disease

Discovery of signaling pathway in immune cells may lead to new therapeutic approach for autoimmune diseases

Study reveals the various ways patients with multiple sclerosis acquire disability

Covid still threatens millions of Americans. Why are we so eager to move on?

Spectrum of autoantibodies linked to autoimmune diseases in patients with different COVID-19 clinical outcomes

Researchers discover how pre-transplant chemotherapy facilitates the replacement of microglial cells

Twin study identifies the influence of environment and genetics in multiple sclerosis

Induction and stability of vaccine-specific antibodies in multiple sclerosis patients on different disease-modifying therapies

Using sugar molecules for in vivo tracking of unlabeled stem cells

Researchers investigate how discontinuing the multiple sclerosis drug affects expectant mothers

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in